BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2859621)

  • 1. 1.2-Anellated 1.4-benzodiazepine derivatives--a new class of antipsychotics.
    Ruhland M; Liepmann H; Muesch HR
    Pharmacopsychiatry; 1985 Jan; 18(1):174-7. PubMed ID: 2859621
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral indications for phenothiazine and benzodiazepine tranquilizers in dogs.
    Hart BL
    J Am Vet Med Assoc; 1985 Jun; 186(11):1192-4. PubMed ID: 2861189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid benzodiazepine tifluadom and drug-induced hyperactivity in mice: lack of benzodiazepine-like effects.
    Sansone M; Castellano C; Pavone F; Hano J
    Pol J Pharmacol Pharm; 1985; 37(5):585-90. PubMed ID: 2870483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'- oxoethyl)piperidine HBr], a potential antipsychotic agent: preclinical behavioral effects.
    Cook L; Tam SW; Rohrbach KW
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1159-66. PubMed ID: 1361571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in chlorpromazine induced CNS effects when associated with other neuroleptics and anxiolytics.
    Pérez-Raya MD; Risco S; Navarro C; Jimenez J; Cabo J
    Pharm Acta Helv; 1989; 64(5-6):146-50. PubMed ID: 2569203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new psychoactive 5H-2,3-benzodiazepine with a unique spectrum of activity.
    Horváth K; Andrási F; Berzsenyi P; Pátfalusi M; Patthy M; Szabó G; Sebestyén L; Bagdy E; Körösi J; Botka P
    Arzneimittelforschung; 1989 Aug; 39(8):894-9. PubMed ID: 2573361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic versus antidepressant activity of sulpiride isomers in the rat.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Adv Biochem Psychopharmacol; 1982; 31():341-6. PubMed ID: 6123224
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of antipsychotic and antianxiety drugs on the morphine abstinence syndrome in rats.
    Baldino F; Cowan A; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1979 Jan; 208(1):63-6. PubMed ID: 32386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuro-pharmacological studies on SB 5833, a new psychotherapeutic agent of the benzodiazepine class.
    Ferrini R; Miragoli G; Taccardi B
    Arzneimittelforschung; 1974 Dec; 24(12):2029-32. PubMed ID: 4156177
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacology and biochemistry of haloperidol.
    Niemegeers CJ; Laduron PM
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):3-8. PubMed ID: 14331
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavioral, anti-dopaminergic, and prohypnotic effects of neuroleptics during and after prolonged treatment.
    Biazzi A; Fregnan GB
    Adv Biochem Psychopharmacol; 1980; 24():351-7. PubMed ID: 6105785
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of pharmacologic substances on the sequelae of emotional excitation in cats].
    Burov IuV; Salimov RM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1974; 24(4):825-32. PubMed ID: 4155848
    [No Abstract]   [Full Text] [Related]  

  • 13. Some behavioral effects of chlorodesmethyldiazepam and lorazepam.
    Kostowski W; Płaźnik A; Puciłowski O; Trzaskowska E; Lipińska T
    Pol J Pharmacol Pharm; 1981; 33(6):597-602. PubMed ID: 6127668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Afobazole decreases motor side effects induced by haloperidol].
    Seredenin SB; Garibova TA; Kuznetsova AL; Voronin MV; Iarkova MA; Voronina TA
    Eksp Klin Farmakol; 2009; 72(1):15-8. PubMed ID: 19334504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of Rauwolfia vomitoria and chlorpromazine on locomotor behaviour and anxiety in mice.
    Bisong SA; Brown R; Osim EE
    J Ethnopharmacol; 2010 Oct; 132(1):334-9. PubMed ID: 20800668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological evaluation of clomacran, a new potent psychotropic agent.
    Fowler PJ; Zirkle CL; Macko E; Kaiser C; Sarau H; Tedeschi DH
    Arzneimittelforschung; 1977; 27(4):866-72. PubMed ID: 17419
    [No Abstract]   [Full Text] [Related]  

  • 18. The synthesis and pharmacology of a novel benzodiazepine derivative, 1-methyl-5-(o-fluorophenyl)-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one(ID-540).
    Asami Y; Otsuka M; Hirohashi T; Inaba S; Yamamoto H
    Arzneimittelforschung; 1974 Oct; 24(10):1563-8. PubMed ID: 4154759
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacology of anti-anxiety drugs with special reference to clobazam.
    Fielding S; Hoffmann I
    Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):7S-15S. PubMed ID: 35209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a thione on sleep disturbances associated with chronic pain.
    Ayala-Guerrero F; Guevara LU; Taboada J; Martinez R
    Proc West Pharmacol Soc; 1993; 36():233-7. PubMed ID: 8104342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.